• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

模拟 SARS-CoV-2 感染的病毒动力学。

Modeling the viral dynamics of SARS-CoV-2 infection.

机构信息

Department of Biology, New York University, New York, NY 10012, United States of America.

Beijing Center for Disease Prevention and Control, Beijing 100013, China; Beijing Research Center for Preventive Medicine, Beijing, China; School of Public Health, Capital Medical University, Beijing, China.

出版信息

Math Biosci. 2020 Oct;328:108438. doi: 10.1016/j.mbs.2020.108438. Epub 2020 Aug 6.

DOI:10.1016/j.mbs.2020.108438
PMID:32771304
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7409942/
Abstract

Coronavirus disease 2019 (COVID-19), an infectious disease caused by the infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is spreading and causing the global coronavirus pandemic. The viral dynamics of SARS-CoV-2 infection have not been quantitatively investigated. In this paper, we use mathematical models to study the pathogenic features of SARS-CoV-2 infection by examining the interaction between the virus, cells and immune responses. Models are fit to the data of SARS-CoV-2 infection in patients and non-human primates. Data fitting and numerical simulation show that viral dynamics of SARS-CoV-2 infection have a few distinct stages. In the initial stage, viral load increases rapidly and reaches the peak, followed by a plateau phase possibly generated by lymphocytes as a secondary target of infection. In the last stage, viral load declines due to the emergence of adaptive immune responses. When the initiation of seroconversion is late or slow, the model predicts viral rebound and prolonged viral persistence, consistent with the observation in non-human primates. Using the model we also evaluate the effect of several potential therapeutic interventions for SARS-CoV-2 infection. Model simulation shows that anti-inflammatory treatments or antiviral drugs combined with interferon are effective in reducing the duration of the viral plateau phase and diminishing the time to recovery. These results provide insights for understanding the infection dynamics and might help develop treatment strategies against COVID-19.

摘要

新型冠状病毒病(COVID-19),是一种由严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染引起的传染病,正在全球范围内传播并引发大流行。SARS-CoV-2 感染的病毒动力学尚未得到定量研究。在本文中,我们使用数学模型通过检查病毒、细胞和免疫反应之间的相互作用来研究 SARS-CoV-2 感染的发病特征。通过拟合 SARS-CoV-2 感染患者和非人类灵长类动物的数据来建立模型。数据拟合和数值模拟表明,SARS-CoV-2 感染的病毒动力学具有几个不同的阶段。在初始阶段,病毒载量迅速增加并达到峰值,随后可能由于淋巴细胞作为感染的次级靶标而进入平台期。在最后阶段,由于适应性免疫反应的出现,病毒载量下降。当血清转换的开始较晚或较慢时,模型预测会出现病毒反弹和病毒持续时间延长,与非人类灵长类动物的观察结果一致。我们还使用该模型评估了几种针对 SARS-CoV-2 感染的潜在治疗干预措施的效果。模型模拟表明,抗炎治疗或抗病毒药物联合干扰素可有效减少病毒平台期的持续时间,并缩短恢复时间。这些结果为理解感染动力学提供了思路,并可能有助于制定针对 COVID-19 的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121e/7409942/b53ea4a2861b/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121e/7409942/af936770a5d2/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121e/7409942/226efbd6340d/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121e/7409942/49506cbd75d8/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121e/7409942/2d4b60372709/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121e/7409942/881f024cbe5b/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121e/7409942/ae49aacd949f/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121e/7409942/76f30e624951/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121e/7409942/b53ea4a2861b/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121e/7409942/af936770a5d2/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121e/7409942/226efbd6340d/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121e/7409942/49506cbd75d8/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121e/7409942/2d4b60372709/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121e/7409942/881f024cbe5b/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121e/7409942/ae49aacd949f/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121e/7409942/76f30e624951/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121e/7409942/b53ea4a2861b/gr8_lrg.jpg

相似文献

1
Modeling the viral dynamics of SARS-CoV-2 infection.模拟 SARS-CoV-2 感染的病毒动力学。
Math Biosci. 2020 Oct;328:108438. doi: 10.1016/j.mbs.2020.108438. Epub 2020 Aug 6.
2
A Model for SARS-CoV-2 Infection with Treatment.SARS-CoV-2 感染与治疗模型。
Comput Math Methods Med. 2020 Sep 1;2020:1352982. doi: 10.1155/2020/1352982. eCollection 2020.
3
Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.《COVID-19 中的每日病毒动力学和固有及适应性免疫反应评估:病例系列》。
mSphere. 2020 Nov 11;5(6):e00827-20. doi: 10.1128/mSphere.00827-20.
4
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.恒河猴初次接触 SARS-CoV-2 可预防再次感染。
Science. 2020 Aug 14;369(6505):818-823. doi: 10.1126/science.abc5343. Epub 2020 Jul 2.
5
Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis.解析 SARS-CoV-2 对 COVID-19 发病机制中宿主线粒体的劫持。
Am J Physiol Cell Physiol. 2020 Aug 1;319(2):C258-C267. doi: 10.1152/ajpcell.00224.2020. Epub 2020 Jun 8.
6
The within-host viral kinetics of SARS-CoV-2.宿主内 SARS-CoV-2 的病毒动力学。
Math Biosci Eng. 2020 Mar 26;17(4):2853-2861. doi: 10.3934/mbe.2020159.
7
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.羟氯喹在非人类灵长类动物中对抗 SARS-CoV-2 感染的应用。
Nature. 2020 Sep;585(7826):584-587. doi: 10.1038/s41586-020-2558-4. Epub 2020 Jul 22.
8
Overview of lethal human coronaviruses.致死性人类冠状病毒概述。
Signal Transduct Target Ther. 2020 Jun 10;5(1):89. doi: 10.1038/s41392-020-0190-2.
9
SARS-CoV-2 infection protects against rechallenge in rhesus macaques.SARS-CoV-2 感染可使恒河猴免受再次感染。
Science. 2020 Aug 14;369(6505):812-817. doi: 10.1126/science.abc4776. Epub 2020 May 20.
10
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.SARS-CoV-2 感染后口咽后唾液样本和血清抗体反应中的病毒载量时间特征:一项观察性队列研究。
Lancet Infect Dis. 2020 May;20(5):565-574. doi: 10.1016/S1473-3099(20)30196-1. Epub 2020 Mar 23.

引用本文的文献

1
Factors Influencing COVID-19 Viral Clearance: Implications for Vaccination and Antiviral Therapy.影响新冠病毒清除的因素:对疫苗接种和抗病毒治疗的启示
Infect Drug Resist. 2025 Aug 21;18:4227-4240. doi: 10.2147/IDR.S515224. eCollection 2025.
2
Intra- and Inter-host Transmission Dynamics of SARS-CoV-2 Through Viral Load Data Analysis.通过病毒载量数据分析研究严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在宿主内和宿主间的传播动力学
Cureus. 2025 Apr 24;17(4):e82955. doi: 10.7759/cureus.82955. eCollection 2025 Apr.
3
Uncovering the impact of infection routes on within-host MPXV dynamics: Insights from a mathematical modeling study.

本文引用的文献

1
Plasma therapy cured a COVID-19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management.血浆疗法治愈了一名病毒脱落持续49天的新冠肺炎患者:临床特征、实验室检查、血浆疗法及对公共卫生管理的启示
MedComm (2020). 2020 May 27;1(1):77-80. doi: 10.1002/mco2.2. eCollection 2020 Jun.
2
Modeling the Epidemic Trend of the 2019 Novel Coronavirus Outbreak in China.中国2019新型冠状病毒疫情流行趋势建模
Innovation (Camb). 2020 Nov 25;1(3):100048. doi: 10.1016/j.xinn.2020.100048. Epub 2020 Sep 28.
3
Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV.
揭示感染途径对宿主内猴痘病毒动态的影响:一项数学建模研究的见解
PLoS Comput Biol. 2025 May 19;21(5):e1013073. doi: 10.1371/journal.pcbi.1013073. eCollection 2025 May.
4
Nonlinear physics perspective and essential disease dynamics of EBV infections and the dynamics of EBV-associated diseases.EBV感染的非线性物理学视角与基本疾病动力学以及EBV相关疾病的动力学
J Biol Phys. 2025 Feb 26;51(1):11. doi: 10.1007/s10867-025-09676-8.
5
Multicenter Evaluation of the QIAstat-Dx and the BioFire Multiplex Panel Tests for the Detection of Respiratory Pathogens.QIAstat-Dx和BioFire多重检测板检测呼吸道病原体的多中心评估
J Med Virol. 2024 Dec;96(12):e70129. doi: 10.1002/jmv.70129.
6
The kinetics of SARS-CoV-2 infection based on a human challenge study.基于人体挑战研究的 SARS-CoV-2 感染动力学。
Proc Natl Acad Sci U S A. 2024 Nov 12;121(46):e2406303121. doi: 10.1073/pnas.2406303121. Epub 2024 Nov 7.
7
Rapid intra-host diversification and evolution of SARS-CoV-2 in advanced HIV infection.在晚期 HIV 感染中,SARS-CoV-2 在宿主内的快速多样化和进化。
Nat Commun. 2024 Aug 22;15(1):7240. doi: 10.1038/s41467-024-51539-8.
8
Viral Rebound After Antiviral Treatment: A Mathematical Modeling Study of the Role of Antiviral Mechanism of Action.抗病毒治疗后病毒反弹:抗病毒作用机制的数学建模研究。
Interdiscip Sci. 2024 Dec;16(4):844-853. doi: 10.1007/s12539-024-00643-w. Epub 2024 Jul 21.
9
A unifying model to explain frequent SARS-CoV-2 rebound after nirmatrelvir treatment and limited prophylactic efficacy.一种统一的模型来解释奈玛特韦治疗后 SARS-CoV-2 频繁反弹和有限的预防效果。
Nat Commun. 2024 Jun 28;15(1):5478. doi: 10.1038/s41467-024-49458-9.
10
Incorporating Intracellular Processes in Virus Dynamics Models.将细胞内过程纳入病毒动力学模型。
Microorganisms. 2024 Apr 30;12(5):900. doi: 10.3390/microorganisms12050900.
I 型干扰素易感性区分 SARS-CoV-2 和 SARS-CoV。
J Virol. 2020 Nov 9;94(23). doi: 10.1128/JVI.01410-20.
4
Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion.撤回说明:严重急性呼吸综合征冠状病毒2通过其刺突蛋白介导的膜融合感染T淋巴细胞。
Cell Mol Immunol. 2020 Aug;17(8):894. doi: 10.1038/s41423-020-0498-4.
5
A systematic review of asymptomatic infections with COVID-19.对 COVID-19 无症状感染的系统评价。
J Microbiol Immunol Infect. 2021 Feb;54(1):12-16. doi: 10.1016/j.jmii.2020.05.001. Epub 2020 May 15.
6
Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series.德国一起旅行相关原发性病例引发的 COVID-19 暴发调查:病例系列研究。
Lancet Infect Dis. 2020 Aug;20(8):920-928. doi: 10.1016/S1473-3099(20)30314-5. Epub 2020 May 15.
7
Respiratory disease in rhesus macaques inoculated with SARS-CoV-2.感染 SARS-CoV-2 的食蟹猕猴的呼吸道疾病。
Nature. 2020 Sep;585(7824):268-272. doi: 10.1038/s41586-020-2324-7. Epub 2020 May 12.
8
Respiratory virus shedding in exhaled breath and efficacy of face masks.呼气中呼吸道病毒的释放和口罩的效果。
Nat Med. 2020 May;26(5):676-680. doi: 10.1038/s41591-020-0843-2. Epub 2020 Apr 3.
9
SARS-CoV-2 productively infects human gut enterocytes.SARS-CoV-2 能有效地感染人类肠道肠细胞。
Science. 2020 Jul 3;369(6499):50-54. doi: 10.1126/science.abc1669. Epub 2020 May 1.
10
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China.从中国武汉的传播动态估计 COVID-19 的临床严重程度。
Nat Med. 2020 Apr;26(4):506-510. doi: 10.1038/s41591-020-0822-7. Epub 2020 Mar 19.